BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Rapamycin
,
rs4950928
,
FXYD4
,
T cell differentiation
,
Leukemia
,
Stem cell
,
Alcohol
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
response to cyclosporin A
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
No tissues found
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Perforation of tympanic membrane
Effect of exposure to physical force
Nerve injury
Pain
Pneumocystosis
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Phalloidine
2-nitroanisole
Deoxycholic Acid
Tgfb1 protein, rat
cumene
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
SAR1B
ABCG2
TCF7L2
POU1F1
SAR1B
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Smooth muscle gene expression profiles in response to arterial level fluid shear stress
Striatal ST14A cells mutant for Huntingtons disease repeats treated with MIND4
Genomics Assisted Toxicity Evaluation system study - Rat Liver Repeat Doses
Drug Matrix In Vivo Toxicogenomic Study - Rat Liver [Affymetrix]
Hepatocytes from male wistar rats treated with 14 hepatotoxicants
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for response to cyclosporin A
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Open-label Study of Subcutaneous Secukinumab to Evaluate Efficacy and Safety in Patients With Plaque…
Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis With Inadeq…
Microvascular and Inflammatory Responses of 0.05 Cyclosporine Eye Drop (II) in Treatment of Dry Eye
Moderate Weight Loss Makes Obese Patients With Severe Chronic Plaque Psoriasis Responsive to Sub-Opt…
Optimization of Cyclosporin in Atopic Dermatitis Through Multiomic Predictive Models of Treatment Re…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ